Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression

Autor: Templeton, AJ, Gonzalez, LD, Vera-Badillo, FE, Tibau, A, Goldstein, R, Seruga, B, Srikanthan, A, Pandiella, A, Amir, E, Ocana, A

Publikováno v: PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background Germline mutations in the BRCA1 and BRCA2 genes are the most frequent known hereditary causes of familial breast cancer. Little is known about the interaction of age at diagnosis, estrogen receptor (ER) and progesterone receptor (PgR) expr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6b973203fc14225c80426c57771a219e
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14388

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Autor: Klümper N; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany., Tran NK; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Zschäbitz S; Department of Medical Oncology, National Center for Tumor Disease (NCT), University Hospital, Heidelberg, Germany., Hahn O; Department of Urology and Pediatric Urology, Julius Maximilians University Medical Center of Würzburg, Würzburg, Germany., Büttner T; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Roghmann F; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany., Bolenz C; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany., Zengerling F; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany., Schwab C; Institute of Pathology, University of Heidelberg, Heidelberg, Germany., Nagy D; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Toma M; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Kristiansen G; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Heers H; Department of Urology, University Hospital Marburg, Marburg, Germany., Ivanyi P; Department of Hemostaseology, Oncology and Stem Cell Transplantation, Medical University Hannover, Hannover, Germany., Niegisch G; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany., Grunewald CM; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany., Darr C; Department of Urology, University Hospital Essen, Essen, Germany., Farid A; Department of Urology, University Medical Center Göttingen, Göttingen, Germany., Schlack K; Department of Urology, University Hospital Münster, Münster, Germany., Abbas M; Department of Pathology, University Hospital Münster, Münster, Germany., Aydogdu C; Department of Urology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Casuscelli J; Department of Urology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Mokry T; Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany., Mayr M; Clinic Ottakring, Institute of Pathology and Microbiology, Wien, Austria., Niedersüß-Beke D; Department of Internal Medicine I, Wilhelminenspital, Wien, Austria., Rausch S; Department of Urology, Eberhard Karls University, Tübingen, Germany., Dietrich D; Department of Otorhinolaryngology, University Medical Center Bonn (UKB), Bonn, Germany., Saal J; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Medical Center Bonn (UKB), Bonn, Germany., Ellinger J; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Ritter M; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany.; BRIDGE-Consortium Germany e.V., Mannheim, Germany., Alajati A; Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Kuppe C; Institute of Experimental Medicine and Systems Biology and Division of Nephrology, RWTH Aachen University, Aachen, Germany., Meeks J; Department of Urology, Feinberg School of Medicine, Chicago, IL., Vera Badillo FE; Department of Medical Oncology, Queen's University, Kingston, Ontario, Canada., Nakauma-González JA; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Boormans J; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg, Germany., Hartmann A; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany., Grünwald V; Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Essen University Hospital, Essen, Germany., Hölzel M; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn, Germany., Eckstein M; BRIDGE-Consortium Germany e.V., Mannheim, Germany.; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2446-2455. Date of Electronic Publication: 2024 Apr 24.

A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 - 2018.

Autor: Moldaver DM; AstraZeneca Canada, Mississauga, ON., Hassan S; HOPE Research Centre, Sunnybrook Research Institute, Toronto, ON., Seung SJ; HOPE Research Centre, Sunnybrook Research Institute, Toronto, ON., Edwin J; AstraZeneca Canada, Mississauga, ON., Clouthier DL; AstraZeneca Canada, Mississauga, ON., Vera-Badillo FE; Department of Oncology, Queen's University, Kingston, ON. Electronic address: Francisco.VeraBadillo@kingstonhsc.ca.

Publikováno v: Urologic oncology [Urol Oncol] 2023 Mar; Vol. 41 (3), pp. 146.e13-146.e22. Date of Electronic Publication: 2023 Jan 12.

Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis.

Autor: Zalay O; Division of Radiation Oncology, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Yan M; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada., Sigurdson S; Department of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada., Malone S; Division of Radiation Oncology, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Vera-Badillo FE; Department of Oncology, Queen's University, Kingston, ON K7L 5P9, Canada.; Canadian Cancer Trials Group, Queen's Cancer Research Institute, Kingston, ON K7L 2V5, Canada., Mahmud A; Department of Oncology, Queen's University, Kingston, ON K7L 5P9, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Dec 20; Vol. 30 (1), pp. 19-36. Date of Electronic Publication: 2022 Dec 20.

Metastatic prostate cancer gets into the biomarker era.

Autor: Vera Badillo FE; Department of Oncology, Queen's University, Kingston, ON, Canada.

Publikováno v: Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2022 Oct; Vol. 16 (10), pp. 333.